Medicare Enrolled

Dr. Nalini Mattai, MD

Dermatology · Pasadena, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
301 S FAIR OAKS AVE STE 405, Pasadena, CA 91105
6267921912
In practice since 2007 (18 years)
NPI: 1982803052 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mattai from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mattai? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mattai

Dr. Nalini Mattai is a dermatology specialist in Pasadena, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Mattai performed 1,723 Medicare services across 911 unique beneficiaries.

Between the years covered by Open Payments, Dr. Mattai received a total of $5,243 from 35 pharmaceutical and/or device companies across 258 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mattai is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 24% volume in CA $5,243 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,723
Medicare services
Top 24% in CA for dermatology
911
Unique beneficiaries
$56
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~96 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
540 $51 $83
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
347 $79 $123
Remote patient monitoring management, 20 min/month
Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month.
128 $40 $60
Chronic care management, first 20 min/month
This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions.
118 $51 $80
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
116 $130 $133
Annual depression screening 111 $20 $30
Remote patient monitoring device, 30 days
Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period.
94 $44 $65
Electrocardiogram (EKG), 12-lead
A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report.
64 $10 $35
Chronic care management, additional 20 min/month
This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month.
52 $39 $58
Remote vital sign monitoring management, each additional 20 minutes
This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period.
52 $32 $48
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
28 $28 $28
Flu vaccine, high-dose
High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe.
24 $72 $76
Blood glucose test using hand-held instrument
A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels.
20 $3 $15
Remote physiologic monitoring setup and education
Initial setup of remote monitoring equipment and patient education on its use.
17 $16 $25
Initial preventive physical examination, new Medicare beneficiary
A comprehensive preventive health visit for new Medicare beneficiaries during their first 12 months of enrollment. The service is conducted as a face-to-face visit and is limited to preventive care.
12 $170 $183
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$5,243
Total received (2018-2024)
Avg $749/year across 7 years
Top 9% in CA for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
35
Companies
258
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,243 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,093
2023
$1,170
2022
$1,094
2021
$403
2020
$455
2019
$493
2018
$535

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$164
Abbott Laboratories
$139
AstraZeneca Pharmaceuticals LP
$118
ABBVIE INC.
$113
GlaxoSmithKline, LLC.
$108
Novo Nordisk Inc
$103
Bausch Health US, LLC
$68
Exact Sciences Corporation
$63
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$58
Merck Sharp & Dohme LLC
$46
Amgen Inc.
$37
SANOFI PASTEUR INC.
$30
Boston Scientific Corporation
$24
Corcept Therapeutics
$22
Top 3 companies account for 38.5% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$668
ABBVIE INC.
$514
GlaxoSmithKline, LLC.
$417
Lilly USA, LLC
$411
AstraZeneca Pharmaceuticals LP
$349
Bausch Health US, LLC
$325
SANOFI PASTEUR INC.
$300
Abbott Laboratories
$268
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$230
Teva Pharmaceuticals USA, Inc.
$158
Boehringer Ingelheim Pharmaceuticals, Inc.
$157
Amgen Inc.
$155
Ironwood Pharmaceuticals, Inc
$146
AbbVie Inc.
$100
Exact Sciences Corporation
$100
Allergan Inc.
$100
Biohaven Pharmaceutical Holding Company Ltd.
$98
PFIZER INC.
$92
Merck Sharp & Dohme LLC
$67
Sanofi Pasteur Inc.
$66
Hologic, LLC
$65
AbbVie, Inc.
$61
Phadia US Inc.
$56
ARBOR PHARMACEUTICALS, INC.
$54
BOSTON SCIENTIFIC CORPORATION
$50
Hologic Sales and Service, LLC
$36
Merck Sharp & Dohme Corporation
$31
Biohaven Pharmaceuticals, Inc.
$29
Boston Scientific Corporation
$24
Amarin Pharma Inc.
$24
Corcept Therapeutics
$22
Astellas Pharma US Inc
$19
Shield Therapeutics Inc
$19
Takeda Pharmaceuticals U.S.A., Inc.
$18
Azurity Pharmaceuticals, Inc.
$16
Top 3 companies account for 30.5% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ADACEL · ADVAIR · AJOVY · APLENZIN · APRISO · APTIMA · AREXVY · Aimovig · AirDuo Digihaler · Aptima HPV · BEXSERO · BREZTRI · CHANTIX · Cologuard Collection Kit · EMGALITY · Edarbi · FARXIGA · FLUBLOK QUADRIVALENT · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FLUZONE HIGH-DOSE · FLUZONE QUADRIVALENT · FLUZONE QUADRIVALENT NORTHERN HEMISPHERE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GARDASIL · ImmunoCAP · JANUVIA · JARDIANCE · Katerzia · Korlym · LINZESS · LO LOESTRIN FE · Linzess · MENQUADFI · MOUNJARO · MYRBETRIQ · NURTEC ODT · ORILISSA · Otezla · Ozempic · PNEUMOVAX 23 · QUADRACEL · QULIPTA · RYBELSUS · Rybelsus · SHINGRIX · SYMBICORT · SYNTHROID · Saxenda · Superion · Synthroid · THINPREP 2000 PROCESSOR · TRELEGY ELLIPTA · TRULICITY · Trintellix · UBRELVY · VAXELIS · VRAYLAR · Vascepa · WAVEWRITER ALPHA · WELLBUTRIN · Wegovy · XIFAXAN · ZEPBOUND
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for dermatology in CA.

Looking for a dermatology specialist in Pasadena?
Compare dermatologists in the Pasadena area by procedure volume, costs, and industry payment transparency.
Browse dermatologists nearby

Geographic Context

Dermatologists within 10 mi
544
Per 100K population
5.5
County median income
$87,760
Nearest hospital
GLENDALE ADVENTIST MEDICAL CENTER
3.1 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Mattai is a clinical cardiology specialist, with above-average Medicare volume (top 24% in CA), with low-engagement industry engagement in the top 9% of CA peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Mattai experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Mattai performed 540 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mattai receive payments from pharmaceutical companies?
Yes. Dr. Mattai received a total of $5,243 from 35 companies across 258 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mattai's costs compare to other dermatologists in Pasadena?
Dr. Mattai's average Medicare payment per service is $56. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mattai) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →